Cannabis Cannabis eases muscle spasms, lowers pain and improves sleep in MS patients: study Existing data is promising, but researchers urge more human trials be done Natalia Buendia CalvilloMarch 24, 2022
Industry update GW Pharma shares soar 21% on rising revenues The cannabinoid drugmaker also launched a Phase 3 trial for a multiple sclerosis treatment Jared GnamNovember 3, 2020
The weed wire Company e-learning platform to help UK doctors get up to speed on weed A partnership with cannabis firm Khiron will teach physicians how to prescribe for pain, anxiety, cancer and epilepsy Michelle GamageAugust 25, 2020
The weed wire U.K. reduces wait times for patients accessing cannabis-based medicines Changes to U.K. laws mean licensed wholesalers can import and store larger quantities of weed Michelle GamageMarch 2, 2020
Medical and Pharmaceutical U.K. approves 2 cannabis-based medicines The medicines, made by GW Pharmaceuticals, are prescribed to treat severe childhood-onset epilepsy and spasticity caused by multiple sclerosis Michelle GamageNovember 13, 2019
CBD GW Pharmaceuticals’ Cannabis-Based Epilepsy Drug Gets EU Approval U.S. Epidiolex sales have surged on strong patient uptake and now the CBD-based epilepsy drug could be sold in 31 European countries after EU... Jared GnamSeptember 24, 2019